Clinical relevance of depressive symptom improvement in bipolar depressed patients treated with olanzapine-fluoxetine combination

被引：0
|
作者：
Williamson, D [1 ]
Brown, E [1 ]
Perlis, R [1 ]
Ahl, J [1 ]
Tollefson, G [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2004年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S216 / S216
页数：1
相关论文
共 50 条
  • [31] Predictive value of bipolar-spectrum clinical features in a large cohort of fluoxetine treated patients with major depressive disorder
    Casamassima, F.
    Fava, M.
    Cassano, G. B.
    Clain, A.
    Kansky, M. S. Christine
    Perlis, R. H.
    [J]. BIPOLAR DISORDERS, 2011, 13 : 34 - 34
  • [32] Association of Common Variations in the Norepinephrine Transporter Gene With Response to Olanzapine-Fluoxetine Combination Versus Continued-Fluoxetine Treatment in Patients With Treatment-Resistant Depression: A Candidate Gene Analysis
    Houston, John P.
    Lau, Kit
    Aris, Virginie
    Liu, Wenlei
    Fijal, Bonnie A.
    Heinloth, Alexandra N.
    Perlis, Roy H.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (06) : 878 - 885
  • [33] Comparison of Pharmacogenomic Associations with Clinical Change in Olanzapine Fluoxetine Combination Treatment of Patients with Treatment Resistant Depression vs. Bipolar I Depression
    Houston, John P.
    Perlis, Roy
    Dharia, Sweta
    Jacobson, Jennie
    Fijal, Bonnie
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 67 (09) : 128S - 128S
  • [34] The relationship between symptom relief and functional improvement during acute fluoxetine treatment for patients with major depressive disorder
    Lin, Ching-Hua
    Chou, Li-Shiu
    Chen, Ming-Chao
    Chen, Cheng-Chung
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 182 : 115 - 120
  • [35] Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: Secondary analyses of a double-blind, placebo-controlled, randomized clinical trial
    Shi, LZ
    Namjoshi, MA
    Swindle, R
    Yu, XM
    Risser, R
    Baker, RW
    Tohen, M
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (01) : 125 - 134
  • [36] ON THE RELATIONSHIP OF NORTRIPTYLINE - AMITRIPTYLINE RATIO TO CLINICAL IMPROVEMENT OF AMITRIPTYLINE TREATED DEPRESSIVE PATIENTS
    JUNGKUNZ, G
    KUSS, HJ
    [J]. PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE, 1980, 13 (03): : 111 - 116
  • [37] Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
    Huang, Jia
    Wang, Yun
    Chen, Jun
    Zhang, Yanlei
    Yuan, Zheng
    Yue, Li
    Maria Haro, Josep
    Victoria Moneta, Maria
    Novick, Diego
    Fang, Yiru
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2473 - 2484
  • [38] RELATIONSHIP BETWEEN CHANGES IN REM-SLEEP AND CLINICAL IMPROVEMENT IN DEPRESSED-PATIENTS TREATED WITH AMITRIPTYLINE
    GILLIN, JC
    WYATT, RJ
    FRAM, D
    SNYDER, F
    [J]. PSYCHOPHARMACOLOGY, 1978, 59 (03) : 267 - 272
  • [39] Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: Secondary analyses of a double-blind, placebo-controlled, randomized clinical trial (vol 26, pg 125, 2004)
    Shi, LZ
    Risser, R
    Namjoshi, MA
    Baker, RW
    Swindle, R
    Tohen, M
    Yu, XM
    [J]. CLINICAL THERAPEUTICS, 2004, 26 (11) : 1934 - 1934
  • [40] Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine
    Gastpar, M
    Masiak, M
    Latif, MA
    Frazzingaro, S
    Medori, R
    Lombertie, ER
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : 32 - 38
12345